Hints and tips:
...The ruling was a significant win for the pharmaceutical companies GSK, Pfizer, Sanofi and Boehringer Ingelheim....
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...The possibility of a Pfizer/AstraZeneca deal still has the politicians talking (the chief executives of both were hauled before the UK parliament this week)....
...beyondbrics India v China: a new race in biopharmaceuticals, beyondbrics...
...Pfizer, the largest US drugmaker by market value, inched down 0.7 per cent to $14.54 as the stock being removed from the “conviction buy” list at Goldman Sachs....
...Call it what you will — but it’s more L-like than V....
...Alphaville’s various posts this week on the growing debate about the equity market recovery – including Wednesday’s insights from The Pragmatic Capitalist and this from Gluskin Sheff chief economist David Rosenberg...
...Last week’s US jobs report has knocked investor confidence, and those predicting a V-shaped recovery are finding it harder to justify their positions....
...This spurred groups such as Pfizer of the US and Roche of Switzerland to strike multi-billion-dollar deals during the first half of this year....
...Kindler, Chairman and CEO, Pfizer Inc., USA Klaus Kleinfeld, President and CEO, Siemens AG, Germany Mustafa V....
...A new Blackstone fund is understood to have an equity target of $4bn for its Real Estate Partners V, which it may reach within weeks – giving it $16bn to spend on global property....
...Wall Street got off to an uncertain start as interest rate concerns were offset by gains for Pfizer after the drugs company won a crucial court case in the UK....
...Pfizer, the drugmaker, rose 2.6 per cent to $29.45 while Wyeth added 3.7 per cent at $40.80....
...He was born in 1954, the year, as he points out, of the famous Brown v Board of Education case which paved the way for US desegregation....
...David Rosenberg, head of US Investment Solutions for Citigroup Private Bank, says: “The way billionaires make their wealth is often the way they are comfortable with investing.”...
International Edition